Variability in the expression of polycomb proteins in different normal and tumoral tissues. A pilot study using tissue microarrays

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
Margarita Sánchez-BeatoMiguel A Piris

Abstract

In spite of the known function of polycomb group (PcG) genes in stem cell self-renewal, control of cellular proliferation and differentiation, its role in cancer pathogenesis is still poorly understood. We studied the expression by immunohistochemistry of several PcG-maintenance complex proteins (RING1, RNF2, BMI1, MEL18, HPH1 and RYBP) in nontumoral (154 samples) and tumoral (550 samples) human tissues using Tissue Microarrays. For selected genes (BMI1 and RING1) FISH analysis has been also carried out. PcG proteins had a tissue- and cell-type-specific expression pattern. Some of them were highly selectively expressed, such as HPH1, which was detected in germ cells in testis, pituitary and parathyroid glands and Langerhans islets, and RYBP, which was found in placenta, umbilical cord and thyroid gland. By contrast, RING1 was ubiquitously expressed in every normal tissue analyzed. Changes in expression associated with tumoral transformation have been found for BMI1 and RNF2, which exhibited increased expression in a large series of tumors, including gastrointestinal tumors, pituitary and parathyroid adenomas, and lymphomas, compared with their expression in normal-cell counterparts. The high level of expression of BMI1 protein ...Continue Reading

References

Mar 6, 1998·Cellular and Molecular Life Sciences : CMLS·M van Lohuizen
May 8, 1998·Biochemical and Biophysical Research Communications·N HashimotoT Higashinakagawa
Dec 22, 1998·Molecular and Cellular Biology·D P Satijn, A P Otte
May 26, 1999·Results and Problems in Cell Differentiation·V Pirrotta
Dec 22, 1999·The Journal of Immunology : Official Journal of the American Association of Immunologists·F M RaaphorstC J Meijer
Sep 12, 2000·The American Journal of Pathology·F M RaaphorstC J Meijer
Feb 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·J M TrimarchiJ A Lees
May 9, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·F M RaaphorstC J Meijer
Jul 17, 2001·Journal of Cellular Biochemistry. Supplement·M J GunsterA P Otte
Mar 15, 2002·Current Opinion in Genetics & Development·Jeffrey A Simon, John W Tamkun
May 22, 2002·Biochimica Et Biophysica Acta·Jacqueline J L Jacobs, Maarten van Lohuizen
Aug 28, 2002·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Fumie MatsuoYoshio Miki
Oct 11, 2002·Nature·Sooryanarayana VaramballyArul M Chinnaiyan
Feb 18, 2003·Proceedings of the National Academy of Sciences of the United States of America·Jan Willem VonckenMaarten van Lohuizen
May 8, 2003·Journal of the National Cancer Institute·Daniel R RhodesMark A Rubin
Sep 23, 2003·Proceedings of the National Academy of Sciences of the United States of America·Celina G KleerArul M Chinnaiyan
Feb 26, 2004·The American Journal of Pathology·Danny F DukersFrank M Raaphorst
Jun 24, 2004·European Journal of Immunology·Joost C van GalenFrank M Raaphorst
Aug 19, 2004·Cell·Merel E Valk-LingbeekMaarten van Lohuizen
Sep 24, 2004·Nature·Hengbin WangYi Zhang

❮ Previous
Next ❯

Citations

Feb 25, 2011·Molecules and Cells·Dongwon Choi, Seongman Kang
Nov 15, 2012·Endocrine Pathology·Boban M ErovicOzgur Mete
Mar 19, 2008·Pathology Oncology Research : POR·Nicolas KozakowskiJohannes Pammer
Jan 16, 2013·Proceedings of the National Academy of Sciences of the United States of America·Wen-jing SuJian Zhang
Feb 21, 2013·Omics : a Journal of Integrative Biology·Jiaofang ShaoBiaoyang Lin
May 11, 2012·PloS One·Bart A WestermanMaarten van Lohuizen
Feb 22, 2011·Journal of Gastrointestinal Cancer·Adrienne GrzendaRaul Urrutia
Apr 28, 2011·International Journal of Hematology·Karin Klauke, Gerald de Haan
Nov 17, 2011·Biochemical and Biophysical Research Communications·Sungsin JoHeekyoung Chung
Jun 19, 2010·The American Journal of Pathology·Daniel Martín-PérezMargarita Sánchez-Beato
Feb 6, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hiroyuki KoikeHideki Taniguchi
Jul 30, 2015·Endocrine-related Cancer·Katharina LampichlerSabina Baumgartner-Parzer
Jun 27, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ji TaoYan-Mei Yang
Feb 28, 2015·Endocrine·Chiara VerdelliSabrina Corbetta
Feb 22, 2012·Free Radical Biology & Medicine·Byung-Wook KimFong-Fong Chu
Aug 19, 2010·Blood·Daniel Martin-PerezMargarita Sanchez-Beato
Feb 18, 2015·Epigenomics·Abdul Aziz KhanTae-Young Roh
Apr 21, 2017·Technology in Cancer Research & Treatment·Huaijun JiZhongmin Jiang
Feb 1, 2018·Journal of Cellular and Molecular Medicine·Shaohua ZhanJinming Li
Feb 22, 2018·Molecular and Cellular Biology·Kazi Mokim AhmedTej K Pandita
May 12, 2016·Biomarkers in Cancer·Anagh A Sahasrabuddhe
Jan 25, 2014·Nature Communications·Qi CaoArul M Chinnaiyan
Jan 24, 2019·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Jie YangShuchai Zhu
Mar 5, 2016·International Journal of Oncology·Xing-Xiao YangShu-Chai Zhu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.